Drug Resistance Conferring Mutation and Genetic Diversity of Mycobacterium tuberculosis Isolates in Tuberculosis Lymphadenitis Patients; Ethiopia.
Sosina AyalewTeklu WegayehuHawult Taye AdaneLiya WassieSelfu GirmaStefan BergAdane MihretPublished in: Infection and drug resistance (2021)
The detection of drug resistant conferring mutation in treatment naïve TBLN patients together with detection of drug resistant isolates among clustered strains might suggest resistant strains' transmission in the community. This needs to be carefully considered to prevent the spread of drug resistant clones in the country.
Keyphrases
- drug resistant
- multidrug resistant
- acinetobacter baumannii
- mycobacterium tuberculosis
- genetic diversity
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- escherichia coli
- prognostic factors
- healthcare
- emergency department
- cystic fibrosis
- real time pcr
- pseudomonas aeruginosa
- patient reported outcomes
- combination therapy